Apoptosis:: the link between autoantibodies and leuko-/lymphocytopenia in patients with lupus erythematosus

被引:22
作者
Böhm, I [1 ]
机构
[1] Univ Bonn, Dept Radiol, D-53105 Bonn, Germany
关键词
D O I
10.1080/03009740410006907
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: To analyse the relation between serum autoantibodies and leuko-/lymphocytopenia in patients with lupus erythematosus ( LE). Methods: Laboratory routine analyses (white blood cell counts, autoantibody detection), and flow cytometry (annexin V, CD3, CD4, CD8, CD95, F(ab) 2 anti-human IgG) have been performed in LE-patients versus healthy controls. In vitro, the influence of pooled serum containing anti-dsDNA antibodies has been analysed on the CD95 expression. Results: Leukocytes, lymphocytes, CD3+, CD3+ CD4+, and CD3+ CD8+ cells from LE-patients were significantly reduced compared with controls. Patients with autoantibodies had significantly lower absolute cell counts than those without. Apoptosis was increased in LE versus controls (p<0.04). The percentage of CD95+ T-cells was increased, and the absolute number of CD95+ cells was reduced in LE. In vitro up-regulation of CD95 could be detected on T-cells of healthy donors. Induction of CD95 seems to be donor-dependent. Conclusion: The data suggest that autoantibodies may be associated with blood cytopenias. CD95 seems to play a central role in this signalling cascade. The underlying mechanism is unclear, but seems to be autoantibody-related apoptosis induction.
引用
收藏
页码:409 / 416
页数:8
相关论文
共 41 条
[1]   ACTIVATION MARKERS ON PERIPHERAL-BLOOD T-CELLS FROM PATIENTS WITH ACTIVE OR INACTIVE SYSTEMIC LUPUS-ERYTHEMATOSUS - CORRELATION WITH PROLIFERATIVE RESPONSES AND PRODUCTION OF IL-2 [J].
ALCOCERVARELA, J ;
ALARCONRIQUELME, M ;
LAFFON, A ;
SANCHEZMADRID, F ;
ALARCONSEGOVIA, D .
JOURNAL OF AUTOIMMUNITY, 1991, 4 (06) :935-945
[2]  
AMASAKI Y, 1995, CLIN EXP IMMUNOL, V99, P245
[3]   Do elevated levels of serum-soluble Fas contribute to the persistence of activated lymphocytes in systemic lupus erythematosus? [J].
Bijl, M ;
van Lopik, T ;
Limburg, PC ;
Spronk, PE ;
Jaegers, SMHJ ;
Aarden, LA ;
Smeenk, RJT ;
Kallenberg, GGM .
JOURNAL OF AUTOIMMUNITY, 1998, 11 (05) :457-463
[4]   Fas expression on peripheral blood lymphocytes in systemic lupus erythematosus (SLE): relation to lymphocyte activation and disease activity [J].
Bijl, M ;
Horst, G ;
Limburg, PC ;
Kallenberg, CGM .
LUPUS, 2001, 10 (12) :866-872
[5]   Anti-CD3-induced and anti-Fas-induced apoptosis in systemic lupus erythematosus (SLE) [J].
Bijl, M ;
Horst, G ;
Limburg, PC ;
Kallenberg, CGM .
CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2001, 123 (01) :127-132
[6]   Disruption of the cytoskeleton after apoptosis induction with autoantibodies [J].
Böhm, I .
AUTOIMMUNITY, 2003, 36 (03) :183-189
[7]  
Bohm Ingrid, 2003, Mol Imaging Biol, V5, P2, DOI 10.1016/S1536-1632(03)00024-6
[8]   Spontaneous and induced apoptosis in systemic lupus erythematosus: Multiple assays fail to reveal consistent abnormalities [J].
Caricchio, R ;
Cohen, PL .
CELLULAR IMMUNOLOGY, 1999, 198 (01) :54-60
[9]   Selective cleavage of nuclear autoantigens during CD95 (Fas/APO-1)-mediated T cell apoptosis [J].
Casiano, CA ;
Martin, SJ ;
Green, DR ;
Tan, EM .
JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 184 (02) :765-770
[10]   Lymphocyte apoptosis in systemic lupus erythematosus: relationships with Fas expression, serum soluble Fas and disease activity [J].
Courtney, PA ;
Crockard, AD ;
Williamson, K ;
McConnell, J ;
Kennedy, RJ ;
Bell, AL .
LUPUS, 1999, 8 (07) :508-513